跳至主要内容
临床试验/JPRN-UMIN000001632
JPRN-UMIN000001632招募中1 期

Vaccination trial with the PBF-derived peptide in HLA-A2+ patients with osteosarcoma - Vaccination trial with the PBF-derived peptide in HLA-A2+ patients with osteosarcoma

Dept Orthopaedic Surgery, Sapporo Medical University0 个研究点目标入组 20 人开始时间: 2009年1月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria included (i) prior chemotherapy, steroid therapy, or other immunotherapy within the past 4 weeks, (ii) presence of severe organ failure or other cancers that might influence the prognosis, (iii) immunodeficiency or a history of splenectomy, (iv) severe cardiac insufficiency, acute infection, or hematopoietic failure, (v) pregnany or ongoing breast-feeding, (vi) unsuitability for the trial based on the clinical judgment of the doctors involved.

研究者

发起方
Dept Orthopaedic Surgery, Sapporo Medical University

相似试验